Potential blockbusters and root-cause treatments from Eli Lilly, Merck, Takeda and others could get a regulatory nod this ...

The U.S. Food and Drug Administration approved the pill version of Wegovy on December 22, marking the first FDA-approved ...

Now the arrival of a Wegovy pill in U.S. pharmacies feels like a line in the sand between the first and second era of ...

After getting the crucial first-mover advantage with an FDA approval for a weight loss pill, Novo Nordisk looks to win the ...

The U.S. Food and Drug Administration has created a "green list" import alert to stop unapproved and unverified glucagon-like peptide 1 (GLP-1) drug ingredients from entering the United States. Due to ...

In coming weeks, Wegovy pill will be available in four doses: a starter dose of 1.5 mg, as well as 4 mg, 9 mg, and 25 mg. As ...

When it comes to cost, the Wegovy pill is expected to be a $25 or less copay per month if covered by insurance. Without ...

Here's when you can get the FDA-approved, daily pill version of Novo Nordisk's wildly popular GLP-1 drug Wegovy.

A new FDA approval for a first-in-class drug has vaulted Otsuka into immunoglobulin A nephropathy (IgAN), an increasingly competitive kidney disease field targeted by multiple biopharma companies. The ...

Elamipretide shows promise in treating Barth syndrome. Advocates hope it will win FDA approval. Walker Burger, who has Barth syndrome, injects the drug elamipretide at his home in Monroe on Friday, ...

Compounded versions of GLP-1 drugs are not approved by the FDA, and serious concerns with these drugs have been identified, including dosing errors, unapproved salt forms, and adverse events that have ...